386 related articles for article (PubMed ID: 19590256)
21. The pharmacological profile of a novel norpregnance progestin (trimegestone).
Philibert D; Bouchoux F; Degryse M; Lecaque D; Petit F; Gaillard M
Gynecol Endocrinol; 1999 Oct; 13(5):316-26. PubMed ID: 10599548
[TBL] [Abstract][Full Text] [Related]
22. [The effect of sodium-4-[2-(2,3-dimethyl-4-[1-(4- isobutylphenyl)ethoxy]benzolamino)phenoxy] butyrate (ONO-3805) and antiandrogenic agents on the rat accessory sex organs].
Takahashi O; Imai K; Watanabe K; Nakazawa Y; Nakata S; Kurita M; Saito Y; Kubota H; Yamanaka H
Hinyokika Kiyo; 1992 Mar; 38(3):305-10. PubMed ID: 1381863
[TBL] [Abstract][Full Text] [Related]
23. 3beta-OH-tibolone acutely dilates rat muscle arterioles similar to 3alpha-OH-tibolone.
Korstjens IJ; van der Mooren MJ; Kloosterboer HJ; Sipkema P
Menopause; 2008; 15(2):386-7. PubMed ID: 18000470
[TBL] [Abstract][Full Text] [Related]
24. Steroid receptors in human renal carcinoma.
Chen L; Weiss FR; Chaichik S; Keydar I
Isr J Med Sci; 1980 Nov; 16(11):756-60. PubMed ID: 7192273
[TBL] [Abstract][Full Text] [Related]
25. Synthesis and biological effect of halogen substituted phenyl acetic acid derivatives of progesterone as potent progesterone receptor antagonists.
Cabeza M; Bratoeff E; Gómez G; Heuze I; Rojas A; Ochoa M; Palomino MA; Revilla C
J Steroid Biochem Mol Biol; 2008 Sep; 111(3-5):232-9. PubMed ID: 18625316
[TBL] [Abstract][Full Text] [Related]
26. Selectivity and potency of the retroprogesterone dydrogesterone in vitro.
Rižner TL; Brožič P; Doucette C; Turek-Etienne T; Müller-Vieira U; Sonneveld E; van der Burg B; Böcker C; Husen B
Steroids; 2011 May; 76(6):607-15. PubMed ID: 21376746
[TBL] [Abstract][Full Text] [Related]
27. Three new epoxy-spirolactone derivatives: characterization in vivo and in vitro.
de Gasparo M; Joss U; Ramjoué HP; Whitebread SE; Haenni H; Schenkel L; Kraehenbuehl C; Biollaz M; Grob J; Schmidlin J
J Pharmacol Exp Ther; 1987 Feb; 240(2):650-6. PubMed ID: 2949071
[TBL] [Abstract][Full Text] [Related]
28. Characterization of 3-methylcholanthrene effects on the rat glucocorticoid receptor in vivo.
Sunahara GI; Guenat C; Grieu F
Cancer Res; 1989 Jul; 49(13):3535-41. PubMed ID: 2731175
[TBL] [Abstract][Full Text] [Related]
29. Relationship between prostatic atrophy and apoptosis in the canine spontaneous benign prostatic hyperplasia (BPH) following chlormadinone acetate (CMA).
Murakoshi M; Ikeda R; Fukui N; Nakayama T
Tokai J Exp Clin Med; 2001 Jul; 26(2):71-5. PubMed ID: 11806444
[TBL] [Abstract][Full Text] [Related]
30. Selective effect of chlormadinone acetate on brain allopregnanolone and opioids content.
Pluchino N; Lenzi E; Merlini S; Giannini A; Cubeddu A; Casarosa E; Begliuomini S; Luisi M; Cela V; Genazzani AR
Contraception; 2009 Jul; 80(1):53-62. PubMed ID: 19501216
[TBL] [Abstract][Full Text] [Related]
31. Drospirenone: a novel progestogen with antimineralocorticoid and antiandrogenic activity.
Muhn P; Fuhrmann U; Fritzemeier KH; Krattenmacher R; Schillinger E
Ann N Y Acad Sci; 1995 Jun; 761():311-35. PubMed ID: 7625729
[TBL] [Abstract][Full Text] [Related]
32. Histopathological studies of subcutaneous implantation of chlormadinone acetate (CMA) for preventing estrus in queens.
Murakoshi M; Tagawa M; Ikeda R
Tokai J Exp Clin Med; 2000 Apr; 25(1):7-10. PubMed ID: 11023049
[TBL] [Abstract][Full Text] [Related]
33. Tetrahydrogestrinone is a potent but unselective binding steroid and affects glucocorticoid signalling in the liver.
Friedel A; Geyer H; Kamber M; Laudenbach-Leschowsky U; Schänzer W; Thevis M; Vollmer G; Zierau O; Diel P
Toxicol Lett; 2006 Jun; 164(1):16-23. PubMed ID: 16356667
[TBL] [Abstract][Full Text] [Related]
34. Immunohistochemical studies in canine prostatic hyperplasia--effect of antiandrogen.
Murakoshi M; Ikeda R; Tagawa M; Nakayama T
Tokai J Exp Clin Med; 1999 Jun; 24(2):77-83. PubMed ID: 10641996
[TBL] [Abstract][Full Text] [Related]
35. Characterization of a new class of selective nonsteroidal progesterone receptor agonists.
Dong Y; Roberge JY; Wang Z; Wang X; Tamasi J; Dell V; Golla R; Corte JR; Liu Y; Fang T; Anthony MN; Schnur DM; Agler ML; Dickson JK; Lawrence RM; Prack MM; Seethala R; Feyen JH
Steroids; 2004 Mar; 69(3):201-17. PubMed ID: 15072922
[TBL] [Abstract][Full Text] [Related]
36. Tibolone and metabolites induce prolactin production in human endometrial stromal cells in vitro: evidence for cell-specific metabolism.
Groothuis PG; De Gooyer ME; ten Kate J; Menheere PP; Dunselman GA; de Goeij AF; Verbost P; Ederveen AG; Kloosterboer HJ
J Steroid Biochem Mol Biol; 2006 Aug; 100(4-5):152-60. PubMed ID: 16781141
[TBL] [Abstract][Full Text] [Related]
37. Medroxyprogesterone acetate: receptor binding and correlated effects on steroidogenesis in rat granulosa cells.
Pridjian G; Schmit V; Schreiber J
J Steroid Biochem; 1987 Mar; 26(3):313-9. PubMed ID: 2953940
[TBL] [Abstract][Full Text] [Related]
38. [The endocrinologic profile of metabolites of the progestin dienogest].
Oettel M; Kaufmann G; Kurischko A
Pharmazie; 1993 Jul; 48(7):541-5. PubMed ID: 8415850
[TBL] [Abstract][Full Text] [Related]
39. Multiple actions of synthetic 'progestins' on the growth of ZR-75-1 human breast cancer cells: an in vitro model for the simultaneous assay of androgen, progestin, estrogen, and glucocorticoid agonistic and antagonistic activities of steroids.
Poulin R; Baker D; Poirier D; Labrie F
Breast Cancer Res Treat; 1991; 17(3):197-210. PubMed ID: 1645605
[TBL] [Abstract][Full Text] [Related]
40. Human osteoblast-like cells contain specific, saturable, high-affinity glucocorticoid, androgen, estrogen, and 1 alpha,25-dihydroxycholecalciferol receptors.
Liesegang P; Romalo G; Sudmann M; Wolf L; Schweikert HU
J Androl; 1994; 15(3):194-9. PubMed ID: 7928659
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
